HAEMONETICS CORP
NYSE: HAESurgical & Medical Instruments & Apparatus · Entity-resolved by Clous
CIK0000313143
TickerHAE
ExchangeNYSE
SIC3841
StateMA
FY end03-28
Key financials
RevenueFY2026-03-28
$1.33B
-2.0% YoY
Net IncomeFY2026-03-28
$97.31M
-42.0% YoY
Total AssetsFY2026-03-28
$2.4B
-2.2% YoY
EquityFY2026-03-28
$796.32M
-3.0% YoY
Shares OutstandingFY2026-03-28
45.45M
—
Operating Cash FlowFY2026-03-28
$293.22M
+61.4% YoY
Market
Market
HAEClose price
$74.17
Market cap
$3.37B
delayed EOD · as of 2026-06-18
Short interest & fails
Fails-to-deliver
SEC CNS fails · semi-monthly34
shares failed · 2026-05-29
2026-05-2934 sh$67.04
2026-05-22136 sh$61.94
2026-05-1921 sh$57.28
2026-05-1581 sh$57.12
2026-05-1373.36K sh$54.01
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
AI business summary — latest 10-K
Summary
The 10‑K filing consists mainly of XBRL tags, dates, and taxonomy references without clear narrative or financial details.
What it means
Provides little substantive information about Haemonetics' operations or results.
What to watch
Await a more complete 10‑K or subsequent filings with actual financial and business disclosures.
Generated from public filings · not investment advice
| Concept | FY2023-04-01 | FY2024-03-30 | FY2025-03-29 | FY2026-03-28 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | — | $1.31B | $1.36B | $1.33B | -2.0% | 100% |
| Net Income | $115.4M | $117.56M | $167.68M | $97.31M | -42.0% | 7% |
| Total Assets | $1.93B | $2.2B | $2.45B | $2.4B | -2.2% | 180% |
| Equity | $818M | $959.96M | $820.84M | $796.32M | -3.0% | 60% |
| Operating Cash Flow | $273.06M | $181.75M | $181.73M | $293.22M | +61.4% | 22% |
| Shares Outstanding | — | — | — | 45.45M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0000313143